Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Kellie Kopp

Physician Assistant, Surgical Reno, NV Physician Assistant

NPI 1326462185 CMS profile 10745708

555 N Arlington Ave, Reno, NV 89503

Open in the dashboard

General payments

$9,611

36 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kellie Kopp of Reno, NV is reported in the CMS Open Payments database as having received $9,611 across 36 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $290 1
2023 General $8,878 14
2022 General $39 2
2021 General $404 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kellie Kopp
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Kellie Kopp were reported at $0. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Kellie Kopp Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $404 $111 $36–$285 $132
2022 $39 $126 $44–$350 $149
2023 $8,878 $137 $47–$355 $160
2024 $290 $146 $49–$384 $164
2025 $0 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Novocure Inc. $9,168 15 payments
  2. Nevro Corp. $125 8 payments
  3. Abbott Laboratories $70 1 payment
  4. Medtronic, Inc. $63 3 payments
  5. Merz Pharmaceuticals, LLC $47 1 payment
  6. Biohaven Pharmaceuticals, Inc. $36 2 payments
  7. Pfizer Inc. $21 1 payment
  8. GRT US Holding, Inc. $21 1 payment
  9. AbbVie, Inc. $18 1 payment
  10. Allergan Inc. $16 1 payment
  11. Other $26 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Compensation for serving as faculty or as a speaker for a medical education program $7,400 6 payments
  2. Travel and Lodging $1,208 4 payments
  3. Food and Beverage $712 25 payments
  4. Consulting Fee $290 1 payment
Products named General payments · program years 2021–2024
  1. Optune $8,878 14 payments
  2. Omnia $125 8 payments
  3. Proclaim IPG $70 1 payment
  4. Xeomin $47 1 payment
  5. NURTEC ODT $36 2 payments
  6. BOTOX $34 2 payments
  7. SYNCHROMED $23 1 payment
  8. SYNCHROMEDII $21 1 payment
  9. REYVOW $21 1 payment
  10. Qutenza $21 1 payment
  11. Other $57 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record